These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30236554)

  • 1. TNF-α suppresses osteogenic differentiation of MSCs by accelerating P2Y
    Du D; Zhou Z; Zhu L; Hu X; Lu J; Shi C; Chen F; Chen A
    Bone; 2018 Dec; 117():161-170. PubMed ID: 30236554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor alpha suppresses osteogenic differentiation of MSCs by inhibiting semaphorin 3B via Wnt/β-catenin signaling in estrogen-deficiency induced osteoporosis.
    Sang C; Zhang Y; Chen F; Huang P; Qi J; Wang P; Zhou Q; Kang H; Cao X; Guo L
    Bone; 2016 Mar; 84():78-87. PubMed ID: 26723579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF-α promotes osteoclastogenesis through JNK signaling-dependent induction of Semaphorin3D expression in estrogen-deficiency induced osteoporosis.
    Sang C; Zhang J; Zhang Y; Chen F; Cao X; Guo L
    J Cell Physiol; 2017 Dec; 232(12):3396-3408. PubMed ID: 28059444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor α suppresses the mesenchymal stem cell osteogenesis promoter miR-21 in estrogen deficiency-induced osteoporosis.
    Yang N; Wang G; Hu C; Shi Y; Liao L; Shi S; Cai Y; Cheng S; Wang X; Liu Y; Tang L; Ding Y; Jin Y
    J Bone Miner Res; 2013 Mar; 28(3):559-73. PubMed ID: 23074166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in C2C12 cells.
    Matsumoto Y; Otsuka F; Takano M; Mukai T; Yamanaka R; Takeda M; Miyoshi T; Inagaki K; Sada KE; Makino H
    Mol Cell Endocrinol; 2010 Aug; 325(1-2):118-27. PubMed ID: 20638987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the osteogenic and adipogenic differentiation of bone marrow-derived stromal cells by extracellular uridine triphosphate: The role of P2Y2 receptor and ERK1/2 signaling.
    Li W; Wei S; Liu C; Song M; Wu H; Yang Y
    Int J Mol Med; 2016 Jan; 37(1):63-73. PubMed ID: 26531757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor inhibits mesenchymal stem cell differentiation into osteoblasts via the ubiquitin E3 ligase Wwp1.
    Zhao L; Huang J; Zhang H; Wang Y; Matesic LE; Takahata M; Awad H; Chen D; Xing L
    Stem Cells; 2011 Oct; 29(10):1601-10. PubMed ID: 21809421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATF3 mediates the inhibitory action of TNF-α on osteoblast differentiation through the JNK signaling pathway.
    Jeong BC
    Biochem Biophys Res Commun; 2018 May; 499(3):696-701. PubMed ID: 29605296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-27a is Essential for the Shift from Osteogenic Differentiation to Adipogenic Differentiation of Mesenchymal Stem Cells in Postmenopausal Osteoporosis.
    You L; Pan L; Chen L; Gu W; Chen J
    Cell Physiol Biochem; 2016; 39(1):253-65. PubMed ID: 27337099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The let-7f-5p-Nme4 pathway mediates tumor necrosis factor α-induced impairment in osteogenesis of bone marrow-derived mesenchymal stem cells.
    Zhao YJ; Gao ZC; He XJ; Li J
    Biochem Cell Biol; 2021 Aug; 99(4):488-498. PubMed ID: 34297624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preconditioning of murine mesenchymal stem cells synergistically enhanced immunomodulation and osteogenesis.
    Lin T; Pajarinen J; Nabeshima A; Lu L; Nathan K; Jämsen E; Yao Z; Goodman SB
    Stem Cell Res Ther; 2017 Dec; 8(1):277. PubMed ID: 29212557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low concentration flufenamic acid enhances osteogenic differentiation of mesenchymal stem cells and suppresses bone loss by inhibition of the NF-κB signaling pathway.
    Liu X; Li Z; Liu H; Zhu Y; Xia D; Wang S; Gu R; Wu W; Zhang P; Liu Y; Zhou Y
    Stem Cell Res Ther; 2019 Jul; 10(1):213. PubMed ID: 31324207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term exposure to tumor necrosis factor-alpha enables human osteoblasts to direct adipose tissue-derived mesenchymal stem cells into osteogenic differentiation.
    Lu Z; Wang G; Dunstan CR; Zreiqat H
    Stem Cells Dev; 2012 Sep; 21(13):2420-9. PubMed ID: 22296271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autocrine fibroblast growth factor 18 mediates dexamethasone-induced osteogenic differentiation of murine mesenchymal stem cells.
    Hamidouche Z; Fromigué O; Nuber U; Vaudin P; Pages JC; Ebert R; Jakob F; Miraoui H; Marie PJ
    J Cell Physiol; 2010 Aug; 224(2):509-15. PubMed ID: 20432451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activator inhibitor-1 deficiency suppresses osteoblastic differentiation of mesenchymal stem cells in mice.
    Takafuji Y; Tatsumi K; Ishida M; Kawao N; Okada K; Matsuo O; Kaji H
    J Cell Physiol; 2019 Jun; 234(6):9687-9697. PubMed ID: 30387130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-α Inhibits FoxO1 by Upregulating miR-705 to Aggravate Oxidative Damage in Bone Marrow-Derived Mesenchymal Stem Cells during Osteoporosis.
    Liao L; Su X; Yang X; Hu C; Li B; Lv Y; Shuai Y; Jing H; Deng Z; Jin Y
    Stem Cells; 2016 Apr; 34(4):1054-67. PubMed ID: 26700816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour necrosis factor-α promotes BMHSC differentiation by increasing P2X7 receptor in oestrogen-deficient osteoporosis.
    Lu J; Zhou Z; Ma J; Lu N; Lei Z; Du D; Chen A
    J Cell Mol Med; 2020 Dec; 24(24):14316-14324. PubMed ID: 33169524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor-alpha inhibits osteogenic differentiation of pre-osteoblasts by downregulation of EphB4 signaling via activated nuclear factor-kappaB signaling pathway.
    Wang LM; Zhao N; Zhang J; Sun QF; Yang CZ; Yang PS
    J Periodontal Res; 2018 Feb; 53(1):66-72. PubMed ID: 28857167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response estrogen promotes osteogenic differentiation via GPR40 (FFAR1) in murine BMMSCs.
    Gao B; Huang Q; Jie Q; Wang L; Zhang HY; Liu J; Yang L; Luo ZJ
    Biochimie; 2015 Mar; 110():36-44. PubMed ID: 25576830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-155 modulates TNF-α-inhibited osteogenic differentiation by targeting SOCS1 expression.
    Wu T; Xie M; Wang X; Jiang X; Li J; Huang H
    Bone; 2012 Sep; 51(3):498-505. PubMed ID: 22634176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.